Apixaban drug utilization study in Stroke prevention in atrial fibrillation (SPAF)

18/04/2016
01/04/2024
EU PAS number:
EUPAS13180
Study
Finalised
Documents
Study protocol
Initial protocol
English (385.13 KB - PDF) View document
Study results
Study results
English (787.47 KB - PDF) View document
Study report
Other information
Publications